Free Trial

Bruker (BRKR) Competitors

Bruker logo
$57.92 +0.11 (+0.19%)
(As of 12:20 PM ET)

BRKR vs. MTD, ILMN, WAT, TECH, CRL, BIO, PACB, HBIO, TMO, and A

Should you be buying Bruker stock or one of its competitors? The main competitors of Bruker include Mettler-Toledo International (MTD), Illumina (ILMN), Waters (WAT), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bio-Rad Laboratories (BIO), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), and Agilent Technologies (A). These companies are all part of the "life sciences tools & services" industry.

Bruker vs.

Mettler-Toledo International (NYSE:MTD) and Bruker (NASDAQ:BRKR) are both computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, community ranking, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment.

Mettler-Toledo International has a net margin of 21.15% compared to Bruker's net margin of 9.41%. Bruker's return on equity of 21.52% beat Mettler-Toledo International's return on equity.

Company Net Margins Return on Equity Return on Assets
Mettler-Toledo International21.15% -531.78% 24.79%
Bruker 9.41%21.52%6.69%

95.1% of Mettler-Toledo International shares are owned by institutional investors. Comparatively, 79.5% of Bruker shares are owned by institutional investors. 1.9% of Mettler-Toledo International shares are owned by company insiders. Comparatively, 28.3% of Bruker shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Mettler-Toledo International has a beta of 1.13, indicating that its share price is 13% more volatile than the S&P 500. Comparatively, Bruker has a beta of 1.18, indicating that its share price is 18% more volatile than the S&P 500.

Mettler-Toledo International has higher revenue and earnings than Bruker. Bruker is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mettler-Toledo International$3.76B6.99$788.78M$37.0933.60
Bruker$3.24B2.67$427.20M$2.0827.49

In the previous week, Mettler-Toledo International had 3 more articles in the media than Bruker. MarketBeat recorded 11 mentions for Mettler-Toledo International and 8 mentions for Bruker. Mettler-Toledo International's average media sentiment score of 1.40 beat Bruker's score of 0.94 indicating that Mettler-Toledo International is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Mettler-Toledo International
8 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Bruker
4 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Bruker received 306 more outperform votes than Mettler-Toledo International when rated by MarketBeat users. Likewise, 64.72% of users gave Bruker an outperform vote while only 56.68% of users gave Mettler-Toledo International an outperform vote.

CompanyUnderperformOutperform
Mettler-Toledo InternationalOutperform Votes
369
56.68%
Underperform Votes
282
43.32%
BrukerOutperform Votes
675
64.72%
Underperform Votes
368
35.28%

Mettler-Toledo International currently has a consensus price target of $1,351.25, suggesting a potential upside of 8.43%. Bruker has a consensus price target of $74.70, suggesting a potential upside of 30.64%. Given Bruker's stronger consensus rating and higher probable upside, analysts clearly believe Bruker is more favorable than Mettler-Toledo International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mettler-Toledo International
1 Sell rating(s)
7 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Bruker
0 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.55

Summary

Mettler-Toledo International beats Bruker on 10 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BRKR vs. The Competition

MetricBrukerAnalytical instruments IndustryComputer SectorNASDAQ Exchange
Market Cap$8.67B$5.54B$24.72B$9.30B
Dividend Yield0.34%0.42%2.69%4.06%
P/E Ratio27.4925.68276.4117.49
Price / Sales2.674.362,830.53136.36
Price / Cash16.6944.4433.7437.95
Price / Book5.672.307.874.92
Net Income$427.20M$2.05M$658.53M$225.42M
7 Day Performance-4.14%-1.20%0.29%-1.20%
1 Month Performance15.73%3.10%10.62%7.09%
1 Year Performance-22.23%-23.82%27.39%22.83%

Bruker Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BRKR
Bruker
4.9938 of 5 stars
$57.92
+0.2%
$74.70
+29.0%
-21.2%$8.78B$3.24B27.859,707Short Interest ↑
MTD
Mettler-Toledo International
4.1379 of 5 stars
$1,267.35
-0.8%
$1,351.25
+6.6%
+4.6%$26.74B$3.76B34.4317,300Positive News
ILMN
Illumina
4.437 of 5 stars
$143.71
-0.1%
$165.95
+15.5%
+12.6%$22.79B$4.39B-14.449,300Short Interest ↑
WAT
Waters
3.8243 of 5 stars
$376.00
-0.6%
$375.85
0.0%
+16.7%$22.33B$2.91B36.097,900
TECH
Bio-Techne
4.3175 of 5 stars
$76.51
+1.1%
$82.00
+7.2%
-0.9%$12.16B$1.17B81.073,100Short Interest ↑
Positive News
CRL
Charles River Laboratories International
4.6361 of 5 stars
$191.76
+0.7%
$214.00
+11.6%
-17.9%$9.81B$4.06B23.8421,800Positive News
BIO
Bio-Rad Laboratories
4.4475 of 5 stars
$339.83
+1.1%
$394.20
+16.0%
+10.2%$9.51B$2.58B-12.308,030Short Interest ↓
Positive News
PACB
Pacific Biosciences of California
1.5354 of 5 stars
$2.05
+4.6%
$2.95
+44.1%
-79.1%$561.41M$200.52M-1.46730
HBIO
Harvard Bioscience
1.126 of 5 stars
$2.12
-1.9%
N/A-55.7%$92.47M$97.73M-6.55490
TMO
Thermo Fisher Scientific
4.8618 of 5 stars
$532.39
+1.0%
$652.30
+22.5%
+2.1%$203.64B$42.86B33.03122,000Analyst Revision
Positive News
A
Agilent Technologies
4.7561 of 5 stars
$137.84
-0.8%
$143.62
+4.2%
-0.2%$39.61B$6.51B31.4518,100Short Interest ↓
Analyst Revision

Related Companies and Tools


This page (NASDAQ:BRKR) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners